title: Barrett's esophagus: proton pump inhibitors and chemoprevention I.
abstract: The following on proton pump inhibitors and chemoprevention in Barrett's esophagus includes commentaries on normalization of esophageal refluxate; the effects of 5-HT(4)  agonists on EGF secretion and of lubripristone on chloride channels agents; the role of Campylobacter toxin production; the deleterious effects of unconjugated bile acids; the role of baclofen in nonacid reflux; the threshold for adequate esophageal acid exposure; the effects of proton pump inhibitor (PPI) therapy on normalization of esophageal pH and on cell proliferation; the role of the phenotype of cellular proliferation on the effects of PPI therapy; and the value of Symptom Index and Symptom Association Probability in the evaluation of potential response to treatment.
authors.affiliation: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
authors.forename: George
authors.initials: G
authors.lastname: Triadafilopoulos
authors.forename: Antonio
authors.initials: A
authors.lastname: Taddei
authors.forename: Paolo
authors.initials: P
authors.lastname: Bechi
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Freschi
authors.forename: Maria Novella
authors.initials: MN
authors.lastname: Ringressi
authors.forename: Duccio Rossi
authors.initials: DR
authors.lastname: Degli'Innocenti
authors.forename: Francesca
authors.initials: F
authors.lastname: Castiglione
authors.forename: Emmanuella
authors.initials: E
authors.lastname: Masini
authors.forename: Marek
authors.initials: M
authors.lastname: Majewski
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Wallner
authors.forename: Jerzy
authors.initials: J
authors.lastname: Sarosiek
authors.forename: John F
authors.initials: JF
authors.lastname: Dillon
authors.forename: Richard C
authors.initials: RC
authors.lastname: McCallum
authors.forename: Katerina
authors.initials: K
authors.lastname: Dvorak
authors.forename: Aaron
authors.initials: A
authors.lastname: Goldman
authors.forename: Philip
authors.initials: P
authors.lastname: Woodland
authors.forename: Daniel
authors.initials: D
authors.lastname: Sifrim
authors.forename: Joel E
authors.initials: JE
authors.lastname: Richter
authors.forename: Michael
authors.initials: M
authors.lastname: Vieth
authors.forename: Helmut
authors.initials: H
authors.lastname: Neumann
authors.forename: Cord
authors.initials: C
authors.lastname: Langner
authors.forename: Norihisa
authors.initials: N
authors.lastname: Ishimura
authors.forename: Yuji
authors.initials: Y
authors.lastname: Amano
authors.forename: Valter Nilton
authors.initials: VN
authors.lastname: Felix
mesh_terms: D001471:Barrett Esophagus / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D018890:Chemoprevention; D006801:Humans; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
chemical_list: D054328:Proton Pump Inhibitors